FibroBiologics, Inc. (FBLG)

NASDAQ: FBLG · Real-Time Price · USD

0.3439

+0.0839 (32.27%)

At close: Jan 7, 2026, 4:00 PM EST

0.3541

+0.0102 (2.97%)

After-hours: Jan 7, 2026, 7:59 PM EST

FibroBiologics Employees

FibroBiologics had 13 employees as of December 31, 2024. The number of employees increased by 3 or 30.00% compared to the previous year.

Employees

13

Change (1Y)

3

Growth (1Y)

30.00%

Revenue / Employee

n/a

Profits / Employee

-$1,423,154

Market Cap

22.88M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	13	3	30.00%
Dec 31, 2023	10	3	42.86%
Dec 31, 2022	7	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

FBLG News

17 hours ago - FibroBiologics CEO Issues Letter to Shareholders - GlobeNewsWire
1 day ago - FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference - GlobeNewsWire
2 days ago - FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease - GlobeNewsWire
7 days ago - FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis - GlobeNewsWire
22 days ago - FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
23 days ago - FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
4 weeks ago - FibroBiologics Files New Patent For Fibroblast Tech To Advance Deeper Into Orthopedics - Benzinga
4 weeks ago - FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions - GlobeNewsWire